Consortium Tracking Tumor Mutations to Guide Lung Cancer Treatment, Clinical Trial Inclusion | GenomeWeb

By Andrea Anderson

CHICAGO (GenomeWeb News) – Members of the Lung Cancer Mutation Consortium are using genetic information to guide treatment and clinical trial participation for individuals with lung adenocarcinoma, Memorial Sloan-Kettering Cancer Center medical oncologist Mark Kris said at the American Society of Clinical Oncology annual meeting here yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.

Apr
11
Sponsored by
Personal Genome Diagnostics

This webinar will provide an overview of genomic alterations that play a role in immunotherapy response.

May
04
Sponsored by
Qiagen

This online seminar will provide an overview of the use of liquid biopsies for cancer recurrence monitoring with a particular focus on colorectal cancer.

May
23
Sponsored by
Agilent Technologies

This webinar will discuss a target enrichment workflow for high-confidence detection of variants.